Three Doctors from Shonan Beauty Clinic and Hada no Aozora Clinic Present Research Findings at “The 44th Annual Meeting of the Japanese Society of Aesthetic Dermatology”
Dr. Kanako Misonou, Dr. Teruo Yamauchi, and Dr. Joji Matsubara report three studies, including reviews focused on treatment safety
IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that three doctors from Shonan Beauty Clinic and Hada no Aozora Clinic, clinics that receive management support from the Company, presented research findings at the 44th Annual Meeting of the Japanese Society of Aesthetic Dermatology, held in Sendai, Miyagi Prefecture, on August 1 and 2, 2026.
The Japanese Society of Aesthetic Dermatology is an academic society dedicated to advancing research in aesthetic dermatology and to sharing knowledge among doctors and other healthcare professionals. Its annual meeting brings together a large number of specialists to present and discuss the latest findings, techniques, and clinical research.
At the 44th meeting, held under the theme “Beauty and Happiness for Everyone,” Dr. Kanako Misonou, Dr. Teruo Yamauchi, and Dr. Joji Matsubara each presented research findings in their respective fields of expertise. Their topics covered medical body contouring (targeted fat reduction), beard laser hair removal, and injectable treatment for under-eye hollows. In addition to sharing insights gained through daily clinical practice and research, the doctors exchanged views with participants on new treatment approaches and their clinical implications.
Two of the three presentations addressed events that may occur after treatment. They examined the actual clinical course and its contributing factors, with the aim of supporting earlier detection and response. Sharing such cases at academic meetings, not only favorable outcomes, is part of ongoing efforts to enhance the safety of treatment.
As technological innovation continues to accelerate in the field of aesthetic healthcare, the importance of knowledge sharing and academic collaboration, beyond the clinical setting alone, has grown considerably. Meeting the increasingly diverse needs of customers requires not only the adoption of advanced techniques, but also a commitment to accumulating and verifying insights from daily clinical practice and applying them to improve the quality of care. SBC Medical remains committed to advancing cutting-edge initiatives through academic activities and exchanges with research institutions, and to upholding the safety, transparency, and enduring value of healthcare.
Overview of “The 44th Annual Meeting of the Japanese Society of Aesthetic Dermatology”
Venue: The Westin Sendai, Sendai Kokusai Hotel, and Koyo Grand Hotel (Sendai, Miyagi Prefecture)
Dates: August 1 (Sat) and 2 (Sun), 2026
Official website: https://shun-convention.jp/bihifu44/
Presentation Titles
Dr. Kanako Misonou (Deputy Director, Shonan Beauty Clinic Shinjuku Main Branch)
“A Case of Undiagnosed Paradoxical Adipose Hyperplasia (PAH) Exacerbated by Repeat Cryolipolysis: An Analysis of Factors Contributing to Missed Diagnosis”
Dr. Teruo Yamauchi (Director, Hada no Aozora Clinic Nakano Ekimae)
“A Study of Severe Upper Lip Edema Following Laser Beard Hair Removal”
Dr. Joji Matsubara (Shonan Beauty Clinic Shinjuku Main Branch)
“Initial Results of a Porcine-Derived Collagen Product for Under-Eye Hollows”
About SBC Medical Group Holdings Incorporated
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp